CP,I think in the past you may have mentioned expecting a final washout of retail before the pps starts to climb. I think this has been it. I will feel very badly for those that sell out at very low targets after years of waiting for this investment to mature. I really think this is just a bump in the road and probably good for us to focus on I/O rather than Docetaxel, but very painful nonetheless. Hoping this team shows Wednesday that they have learned something from the aftermath of 9/12 and have a viable plan in place to move forward as rapidly as possible.
Market Data 
Markets 
AI
